| Status | Study |
| Recruiting |
Study Name: Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Condition: Tuberous Sclerosis Complex Date: 2016-08-30 |
| Recruiting |
Study Name: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Condition: Sporadic Angiomyolipomas (AMLs) Date: 2015-08-20 Interventions: Drug: Everolimus 10 mg tablets |
| Recruiting |
Study Name: Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Condition: Tuberous Sclerosis Lymphangioleiomyomatosis Date: 2014-12-14 |
| Recruiting |
Study Name: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Condition: Renal Angiomyolipomas Tuberous Sclerosis Date: 2014-04-01 Interventions: Drug: Propranolol |
| Withdrawn |
Study Name: A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Condition: Malignant PEComa (Perivascular Epithelioid Cell Tumors) Date: 2012-09-06 Interventions: Drug: BEZ235 Patients will be provided with an adequate supply of study treatment for self-administratio |
| Completed |
Study Name: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Condition: Angiomyolipoma Date: 2010-10-06 Interventions: Drug: Sirolimus plasma levels between 4 and 8 Other |
| Completed |
Study Name: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Condition: Tuberous Sclerosis Angiolipoma Date: 2008-11-17 Interventions: Drug: everolimus (RAD001) Subjects will resume the dosing regimen that they were receiving at the comple |
| Completed |
Study Name: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Condition: Tuberous Sclerosis Complex (TSC) Lymphangioleiomyomatosis (LAM) Date: 2008-11-10 Interventions: Drug: Everolimus (RAD001) Ever |
| Completed |
Study Name: Tuberous Sclerosis Complex Natural History Study: Renal Manifestations Condition: Tuberous Sclerosis Complex Date: 2007-12-27 |
| Completed |
Study Name: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Condition: Tuberous Sclerosis Lymphangioleiomyomatosis Date: 2007-04-06 Interventions: Drug: RAD001 5 and 10 mg/day or 30, 50, 70mg/week |